MedPath

Desmopressin Acetate

Desmporessin Acetate Tablets 0.1 mg, 0.2 mg

Approved
Approval ID

72aeef35-c102-b628-0219-9822651887eb

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 31, 2023

Manufacturers
FDA

Apotex Corp.

DUNS: 845263701

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

desmopressin acetate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code60505-0258
Application NumberANDA077414
Product Classification
M
Marketing Category
C73584
G
Generic Name
desmopressin acetate
Product Specifications
Route of AdministrationORAL
Effective DateMarch 31, 2023
FDA Product Classification

INGREDIENTS (4)

DESMOPRESSIN ACETATEActive
Quantity: 0.2 mg in 1 1
Code: XB13HYU18U
Classification: ACTIB
LACTOSE, UNSPECIFIED FORMInactive
Code: J2B2A4N98G
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT

desmopressin acetate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code60505-0257
Application NumberANDA077414
Product Classification
M
Marketing Category
C73584
G
Generic Name
desmopressin acetate
Product Specifications
Route of AdministrationORAL
Effective DateMarch 31, 2023
FDA Product Classification

INGREDIENTS (4)

DESMOPRESSIN ACETATEActive
Quantity: 0.1 mg in 1 1
Code: XB13HYU18U
Classification: ACTIB
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
LACTOSE, UNSPECIFIED FORMInactive
Code: J2B2A4N98G
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Desmopressin Acetate - FDA Drug Approval Details